Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) Return on Invested Capital (2021 - 2025)

Biofrontera has reported Return on Invested Capital over the past 5 years, most recently at 2.88% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 2.88% for Q4 2025, up 58.0% from a year ago — trailing twelve months through Dec 2025 was 2.88% (up 58.0% YoY), and the annual figure for FY2025 was 1.53%, up 110.0%.
  • Return on Invested Capital for Q4 2025 was 2.88% at Biofrontera, down from 4.87% in the prior quarter.
  • Over the last five years, Return on Invested Capital for BFRIW hit a ceiling of 18.02% in Q4 2021 and a floor of 21.2% in Q2 2021.
  • Median Return on Invested Capital over the past 5 years was 1.58% (2022), compared with a mean of 1.51%.
  • Peak annual rise in Return on Invested Capital hit 1962bps in 2022, while the deepest fall reached -1871bps in 2022.
  • Biofrontera's Return on Invested Capital stood at 18.02% in 2021, then crashed by -104bps to 0.69% in 2022, then plummeted by -289bps to 2.68% in 2023, then decreased by -29bps to 3.46% in 2024, then grew by 17bps to 2.88% in 2025.
  • The last three reported values for Return on Invested Capital were 2.88% (Q4 2025), 4.87% (Q3 2025), and 7.83% (Q2 2025) per Business Quant data.